Chiome Bioscience (TSE:4583) Institutional Ownership: 0.20% (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4583 Chiome Bioscience Inc TSE:4583
42 GF Score
Price 円70.00
GF Value 円105.67
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Chiome Bioscience Institutional Ownership?

Chiome Bioscience TSE:4583 +1.45% 42 Institutional Ownership is 0.20% as of Aug. 06, 2026. GuruFocus rates TSE:4583 with a GF Score™ of 42/100 and a GF Value™ of 円105.67 (Possible Value Trap). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Chiome Bioscience's institutional ownership is 0.20%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Chiome Bioscience's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Chiome Bioscience's Float Percentage Of Total Shares Outstanding is 0.00%.

Chiome Bioscience Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Chiome Bioscience's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chiome Bioscience Institutional Ownership Chart

Chiome Bioscience Historical Data

The historical data trend for Chiome Bioscience can be seen below:

2024-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.59 0.30 0.30 0.27 0.24 0.24 0.22 0.20 0.19 0.20
TSE:4583
42GF Score
Chiome Bioscience Inc TSE:4583
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chiome Bioscience Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.20% mean?
Chiome Bioscience (TSE:4583) has a Institutional Ownership of 0.20% as of Aug. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chiome Bioscience and its competitors.
Is Chiome Bioscience's Institutional Ownership too high?
Chiome Bioscience's current Institutional Ownership is 0.20%. Overall, Chiome Bioscience has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chiome Bioscience's Institutional Ownership compare to VRTX and REGN?
Chiome Bioscience's Institutional Ownership of 0.20% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chiome Bioscience and its competitors. Chiome Bioscience's current Institutional Ownership is 0.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chiome Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Chiome Bioscience (TSE:4583) is currently considered Possible Value Trap. The stock's GF Value™ is 円105.67, compared to a current price of 円70.00 — trading 33.8% below its estimated fair value. The current Institutional Ownership is 0.20%. Chiome Bioscience's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Chiome Bioscience (TSE:4583), the current Institutional Ownership is 0.20% as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chiome Bioscience (TSE:4583) Overvalued in 2026?

Based on GuruFocus' analysis, Chiome Bioscience stock appears to be undervalued. The current stock price of 円70.00 is trading 33.8% below its estimated GF Value™ of 円105.67. GuruFocus considers Chiome Bioscience to be Possible Value Trap.

Key valuation signals for TSE:4583:

  • Institutional Ownership: 0.20%
  • GF Value™: 円105.67 vs. price of 円70.00 (33.8% below fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the TSE:4583 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chiome Bioscience Business Description

Address 3-12-1 Honmachi, No. 6, Sumitomo Fudosan Nishi Shinjuku Building, Shibuya-ku, Tokyo, JPN, 151-0071
Chiome Bioscience Inc is engaged in the discovery and development of antibody drugs, focusing on early-stage research and initial clinical trials. The company operates through two reportable segments: the Drug Discovery segment and the Drug Discovery Support segment. The Drug Discovery segment conducts research on antibody creation for diseases with high unmet medical needs and aims to generate revenue through licensing agreements, upfront payments, milestone payments, and royalties. The Drug Discovery Support segment provides services such as antibody production and related support using proprietary antibody technologies, catering to pharmaceutical and diagnostic companies as well as academic institutions.
42GF Score

Get the complete analysis for TSE:4583

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円70.00
Price
円105.67
GF Value